SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $102,000 | -62.2% | 11,300 | -50.0% | 0.00% | – |
| Q2 2021 | $270,000 | +365.5% | 22,600 | +391.3% | 0.00% | – |
| Q1 2021 | $58,000 | -85.3% | 4,600 | 0.0% | 0.00% | – |
| Q4 2020 | $395,000 | +797.7% | 4,600 | 0.0% | 0.00% | – |
| Q3 2020 | $44,000 | +4.8% | 4,600 | 0.0% | 0.00% | – |
| Q2 2020 | $42,000 | +180.0% | 4,600 | +100.0% | 0.00% | – |
| Q1 2020 | $15,000 | -21.1% | 2,300 | 0.0% | 0.00% | – |
| Q4 2019 | $19,000 | +850.0% | 2,300 | +1252.9% | 0.00% | – |
| Q3 2019 | $2,000 | -85.7% | 170 | -86.9% | 0.00% | – |
| Q2 2019 | $14,000 | +16.7% | 1,300 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | +20.0% | 1,300 | +52.9% | 0.00% | – |
| Q4 2018 | $10,000 | -28.6% | 850 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | +16.7% | 850 | 0.0% | 0.00% | – |
| Q2 2018 | $12,000 | +33.3% | 850 | +88.9% | 0.00% | – |
| Q1 2018 | $9,000 | +28.6% | 450 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | – | 450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |